Patent: 7,208,162
✉ Email this page to a colleague
Summary for Patent: 7,208,162
Title: | Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
Abstract: | Therapeutically effective anti-viral compositions, useful especially against respiratory diseases caused or mediated by respiratory syncytial virus (RSV) are disclosed, wherein said compositions comprise at least one anti-RSV antibody, including high affinity antibodies, and an additional anti-inflammatory agent, especially corticosteroids, as well as anti-inflammatory antibodies, especially anti-interleukin-6. Also disclosed are methods of using such compositions to treat and/or prevent respiratory diseases. Such compositions may optionally contain other non-antibody anti-viral agents. |
Inventor(s): | Prince; Gregory (Potomac, MD), Johnson; Leslie S. (Germantown, MD) |
Assignee: | MedImmune, Inc. (Gaithersburg, MD) Virion Systems, Inc. (Rockville, MD) |
Application Number: | 09/848,377 |
Patent Claims: | see list of patent claims |
Details for Patent 7,208,162
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2020-05-03 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | Injection | 103770 | 07/23/2004 | ⤷ Try a Trial | 2020-05-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |